VOWST
Biological
AIMMUNE THERAPEUTICS, INC.
Total Payments
$475,263
Transactions
10,994
Doctors
5,569
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $225,115 | 6,942 | 3,581 |
| 2023 | $250,148 | 4,052 | 2,739 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $244,292 | 10,057 | 51.4% |
| Unspecified | $133,746 | 52 | 28.1% |
| Honoraria | $46,005 | 12 | 9.7% |
| Space rental or facility fees (teaching hospital only) | $32,300 | 15 | 6.8% |
| Education | $14,194 | 847 | 3.0% |
| Travel and Lodging | $2,447 | 9 | 0.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,199 | 1 | 0.3% |
| Consulting Fee | $1,080 | 1 | 0.2% |
Payments by Type
General
$341,516
10,942 transactions
Research
$133,746
52 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| ECOSPOR IV: An Open-Label Extension of Study SERES-012 and Open-Label Program for Evaluating SER-109 in Subjects With Recurrent Clostridioides Difficile Infection (RCDI) | Seres Therapeutics, Inc. | $128,861 | 0 |
| ECOSPOR: A RandomizEd, Double Blind, Placebo COntrolled, Parallel Group Study of SER 109 to Prevent Recurrent ClOstRidium Difficile Infection | Seres Therapeutics, Inc. | $4,885 | 0 |
Top Doctors Receiving Payments for VOWST — Page 5
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Internal Medicine | Omaha, NE | $240.67 | 4 |
| , MD | Specialist | Oak Lawn, IL | $239.14 | 12 |
| , PA-C | Behavior Technician | Bloomington, IL | $238.17 | 15 |
| , PA-C | Medical | Glendale, AZ | $237.12 | 5 |
| , M.D | Surgery | Sioux City, IA | $236.57 | 3 |
| , M.D | Internal Medicine | Loma Linda, CA | $235.80 | 17 |
| , NP | Nurse Practitioner | Mission Viejo, CA | $235.66 | 6 |
| , MD | Family Medicine | Milwaukee, WI | $234.88 | 2 |
| , MD | Gastroenterology | Santa Ana, CA | $234.68 | 2 |
| , MD | General Acute Care Hospital | New York, NY | $233.47 | 2 |
| , MD | Infectious Disease | New York, NY | $233.47 | 2 |
| , MD | Internal Medicine | Bloomington, IL | $232.84 | 16 |
| , MD | Family Medicine | Lincoln, NE | $231.88 | 3 |
| , MD | Gastroenterology | Chesterfield, MO | $231.46 | 12 |
| Dorna Yaghoobzadeh | Medical | Los Angeles, CA | $231.34 | 8 |
| , NP | Gastroenterology | Ridgewood, NY | $230.61 | 3 |
| , M.D | Infectious Disease | Springfield, IL | $228.79 | 15 |
| , NP | Family | Peoria, IL | $228.54 | 16 |
| , MD | Gastroenterology | New York, NY | $226.82 | 11 |
| , M.D | Internal Medicine | Poway, CA | $225.92 | 10 |
| , M.D | Infectious Disease | Newport Beach, CA | $223.94 | 10 |
| , APRN, CNP | Family | Champaign, IL | $223.69 | 12 |
| George Atia | — | Barrington, IL | $223.62 | 13 |
| , M.D | Gastroenterology | Beverly Hills, CA | $222.88 | 8 |
| Tejal Mehta | Infectious Disease | Hillsborough, NJ | $222.81 | 17 |
Ad
Manufacturing Companies
- AIMMUNE THERAPEUTICS, INC. $263,176
- Seres Therapeutics, Inc. $139,022
- NESTLE HEALTHCARE NUTRITION INC. $73,065
Product Information
- Type Biological
- Total Payments $475,263
- Total Doctors 5,569
- Transactions 10,994
About VOWST
VOWST is a biological associated with $475,263 in payments to 5,569 healthcare providers, recorded across 10,994 transactions in the CMS Open Payments database. The primary manufacturer is AIMMUNE THERAPEUTICS, INC..
Payment data is available from 2023 to 2024. In 2024, $225,115 was paid across 6,942 transactions to 3,581 doctors.
The most common payment nature for VOWST is "Food and Beverage" ($244,292, 51.4% of total).
VOWST is associated with 2 research studies, including "ECOSPOR IV: An Open-Label Extension of Study SERES-012 and Open-Label Program for Evaluating SER-109 in Subjects With Recurrent Clostridioides Difficile Infection (RCDI)" ($128,861).